Denali Therapeutics Inc (DNLI)
16.79
+0.63
(+3.90%)
USD |
NASDAQ |
May 02, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Free Cash Flow: -370.93M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -370.93M |
| September 30, 2023 | -347.55M |
| June 30, 2023 | -321.22M |
| March 31, 2023 | -247.99M |
| December 31, 2022 | -262.55M |
| September 30, 2022 | -253.58M |
| June 30, 2022 | -233.80M |
| March 31, 2022 | -243.00M |
| December 31, 2021 | -219.89M |
| September 30, 2021 | 361.38M |
| June 30, 2021 | 404.07M |
| March 31, 2021 | 415.39M |
| December 31, 2020 | 413.06M |
| Date | Value |
|---|---|
| September 30, 2020 | -150.08M |
| June 30, 2020 | -182.74M |
| March 31, 2020 | -192.52M |
| December 31, 2019 | -169.50M |
| September 30, 2019 | -27.33M |
| June 30, 2019 | -29.72M |
| March 31, 2019 | -18.67M |
| December 31, 2018 | 46.72M |
| September 30, 2018 | -64.43M |
| June 30, 2018 | -51.05M |
| March 31, 2018 | -26.79M |
| December 31, 2017 | -79.51M |
Free Cash Flow Range, Past 5 Years
-370.93M
Minimum
Dec 2023
415.39M
Maximum
Mar 2021
-87.29M
Average
-192.52M
Median
Mar 2020
Free Cash Flow Benchmarks
| Halozyme Therapeutics Inc | 373.28M |
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -98.66M |
| Cash from Investing (Quarterly) | 73.05M |
| Cash from Financing (Quarterly) | 4.705M |
| Free Cash Flow Per Share (Quarterly) | -0.7298 |
| Free Cash Flow Yield | -15.97% |